N(w)-Hydroxy L-Arginine (NOHA): A Promising Biomarker of Response to Neoadjuvant Therapy in the Management of Triple Negative Breast Cancer.
- DOI
- 10.1002/cnr2.70609
- Published
- 2026 Jul
- Container
- Cancer reports (Hoboken, N.J.)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/cnr2.70609,
title = {N(w)-Hydroxy L-Arginine (NOHA): A Promising Biomarker of Response to Neoadjuvant Therapy in the Management of Triple Negative Breast Cancer.},
author = {Mohan S and Van Pelt DW and Saunders JG and DiPalazzo J and Monahan SE and Buchsbaum RJ and Frankenfeld CL and Bertaux BY and Miesfeldt S},
year = {2026},
journal = {Cancer reports (Hoboken, N.J.)},
doi = {10.1002/cnr2.70609},
url = {https://doi.org/10.1002/cnr2.70609}
}RIS
TY - JOUR TI - N(w)-Hydroxy L-Arginine (NOHA): A Promising Biomarker of Response to Neoadjuvant Therapy in the Management of Triple Negative Breast Cancer. AU - Mohan S AU - Van Pelt DW AU - Saunders JG AU - DiPalazzo J AU - Monahan SE AU - Buchsbaum RJ AU - Frankenfeld CL AU - Bertaux BY AU - Miesfeldt S PY - 2026 JO - Cancer reports (Hoboken, N.J.) DO - 10.1002/cnr2.70609 UR - https://doi.org/10.1002/cnr2.70609 ER -
APA
S, M., DW, V. P., JG, S., J, D., SE, M., RJ, B., CL, F., BY, B., & S, M. (2026). N(w)-Hydroxy L-Arginine (NOHA): A Promising Biomarker of Response to Neoadjuvant Therapy in the Management of Triple Negative Breast Cancer.. Cancer reports (Hoboken, N.J.). https://doi.org/10.1002/cnr2.70609
Source records
- pubmed · retrieved 2026-09-27T00:38:49.293Z